Immunophotonics, Inc.

Immunophotonics, Inc. co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking place November 7th to 9th in Monte Carlo. They will engage with industry partners and clinical experts globally, focusing on the latest breakthrough technologies for surgical interventions. Look for Lu and Tomas at this event for an opportunity to find out more about how Immunophotonics innovative approach could transform standard treatments into powerful immunotherapies with IP-001 turning every procedure into an opportunity to mobilize the body’s natural immune system against cancer.   Check out our website: www.immumophotonics.com #interventionaloncology #ablation #immunooncology #cancer #immunotherapy #Immunophotonics #clinicaltrials #innovation #abscopalize_it #oncology #oncologyresearch #interventionalradiology #medicaloncology #trials #healthcareexcellence #AngioLifeSymposium

We are thrilled about our new collaboration with the Cardiovascular and Interventional Radiological Society of Europe and Immunophotonics, Inc. on the INJECTABL-3 clinical trial that will evaluate IP-001 in combination with ablation treatments, aiming to reduce or eliminate tumour recurrence. This phase 2/3 trial expects to enrol an estimated 300-500 patients from the United States and Europe holding promise for a new treatment approach in cancer care. Read more about it 👇 CIRSE insider: https://lnkd.in/deV-bBBQ Press release: https://lnkd.in/g7ES4twt #NextResearch #CIRSE #Immunophotonics #ClinicalTrials #Innovation #CancerResearch #ImmunoOncology #InterventionalOncology

Immunophotonics, Inc. CEO Lu Alleruzzo is excited to announce his participation at the ThinkEquity LLC Conference at the Mandarin Oriental, New York on October 30th. Check out his presentation at 12 pm ET in the South Salon II and learn how Immunophotonics is pioneering Interventional Immuno-Oncology™ in treating the disease, not just the tumor.   Feel free to reach out to Lu at ( https://lnkd.in/gsgMjyfZ ), to meet at the event, or for more information. Official press release: https://lnkd.in/gmiEd388 www.immunophotonics.com #research #interventionaloncology #immunooncology #cancer #immunotherapy #Immunophotonics #clinicaltrials #innovation #abscopalize_it #oncology #oncologyresearch #interventionalradiology #medicaloncology #trials #healthcareexcellence #biotechnology #drugdevelopment #antibody #cancerimmunity #immunophotonics 

Interventional Oncology (IO) Week, organized by the Society of Interventional Oncology (SIO) for the fourth consecutive year, aims to raise awareness about this subspecialty of radiology that focuses on treating cancer through targeted, minimally invasive procedures performed with image guidance. Both interventional oncology and immuno-oncology play crucial roles in the battle against cancer, making this a truly remarkable campaign. Immunophotonics, Inc. expresses heartfelt gratitude and extends a big thank you to the interventional oncology professionals and their teams worldwide for their hard work and commitment to advancing cancer care with these innovative procedures. To learn more about IO awareness week: https://lnkd.in/dFE-PP8e #IOAwarenessweek #IKnowIO #SIO #interventionaloncology #ablation #immunooncology #cancer #immunotherapy #Immunophotonics #clinicaltrials #innovation #abscopalize_it #oncology #oncologyresearch #interventionalradiology #medicaloncology #trials #healthcareexcellence #technology

Congratulations to Professor Wei Chen and his lab University of Oklahoma for their publication titled “Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells” in Elsevier Cancer Letters an international journal providing a forum for original and significant contributions in cancer research. Publication: https://lnkd.in/gvAT9C7F Visit our website at: www.immunophotonics.com #interventionaloncology #ablation #immunooncology #cancer #immunotherapy #Immunophotonics #clinicaltrials #innovation #abscopalize_it #oncology #oncologyresearch #interventionalradiology #medicaloncology #trials #healthcareexcellence #technology #innovation #cancer #cancerletters

Siu Kit “Samuel” Lam, PhD, Senior Vice President of Science & Research at Immunophotonics, Inc. attended the SITC Immuno-Oncology Drug Development Summit held in Boston from September 30 – October 1, 2024.     The program was highly informative, offering valuable insights, essential resources, and best practices for the development of immuno-oncology therapeutics. It also provided opportunities to build relationships with regulatory agencies and industry professionals to discuss effective strategies for designing successful clinical trials. www.immunophotonics.com #SITC2024 #interventionaloncology #ablation #immunooncology #cancer #immunotherapy #Immunophotonics #clinicaltrials #innovation #abscopalize_it #oncology #oncologyresearch #interventionalradiology #medicaloncology #trials #healthcareexcellence #technology

𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝗶𝘀 𝗟𝗶𝘃𝗲𝗿 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 Liver cancer may only account for 2% of new cancer cases in the US each year, but it represents nearly 5% of all cancer-related deaths. With a 5-year relative survival rate of just 21.7%, it’s clear that more must be done to fight this disease. 𝗘𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳𝗳𝗲𝗿𝘀 𝗵𝗼𝗽𝗲: 44% of patients are diagnosed at an early stage, where curative treatments like surgery, ablation, and transplantation are available. However, even with these interventions, the 5-year overall survival rate remains only 37%. This underscores a crucial need for new strategies that can extend survival and improve quality of life. That’s why I’m excited to share that we are actively enrolling patients in an exciting clinical trial “𝗔𝗱𝗷𝘂𝘃𝗮𝗻𝘁 𝗜𝗣-𝟬𝟬𝟭 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗛𝗖𝗖 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗙𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗦𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗔𝗯𝗹𝗮𝘁𝗶𝗼𝗻 𝗼𝗿 𝗔𝗯𝗹𝗮𝘁𝗶𝗼𝗻 𝗔𝗹𝗼𝗻𝗲.” Our research aims to determine whether adding an adjuvant immunotherapy after curative treatment can reduce recurrence and improve long-term survival outcomes. If you or someone you know has been diagnosed with hepatocellular carcinoma (HCC), please feel free to reach out. Immunophotonics, Inc. #livercancerawareness #livercancerawarenessmonth #immunotherapy #immunooncology #surgicaloncology #HPB #ablation

Pulling for *our* guy [edited] Lu Alleruzzo of Immunophotonics, Inc. to win Pegasus Tech Ventures' Startup World Cup and bring back the hardware from my hometown of San Francisco to my new home in Saint Louis! 🏆 After winning the St. Louis competition, Lu battled through the flu and jet lag to really dial-in his pitch with me for the finals.💪🏽 Regardless of the outcome, I'm so proud that he is representing our city - I can't think of a better person to showcase the resilience, intelligence, and innovation present in the Midwest region's founder community.🔥 cc: Rick Holton, Jr., Atul Kamra, Julia Campbell, Cultivation Capital, TechSTL #fuckcancer #startupworldcup #stl

Immunophotonics, Inc. wants to congratulate Professor Wei Chen and his lab University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K. Lam, Tomas Hode, PhD, David W. Anderson, Johnny Wong, Abby Delawder, Joseph Raker of Immunophotonics, for their publication titled “N-dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL-1β Productions of Antitumor Immunity.” in Advanced Science News – Advanced Functional Materials. This is a top-tier journal that published outstanding research. Publication:  https://lnkd.in/eHfW_NjD #interventionaloncology #ablation #immunooncology #cancer #immunotherapy #Immunophotonics #clinicaltrials #innovation #abscopalize_it #oncology #oncologyresearch #interventionalradiology #medicaloncology #trials #healthcareexcellence #technology #innovation #cancer

As the St. Louis delegation of founders prepare for the Startup World Cup this week, we want to rally around Lu Alleruzzo, CEO of Immunophotonics, Inc.! We know that all of our companies will represent #StLouis well and the whole community is cheering on Lu as he competes against 70 other startups for the $1 Million prize in Silicon Valley. Congrats again to Immunophotonics, Inc., Capacity, AirSeal CardioVascular, TimeBolt.io, TransitChat, Bold Spoon Creamery, King of the Curve (KOTC), SimpleRose, SAYeTECH, Muia Materials who all were invited to participate in this week's Startup World Cup in San Francisco!